Related Experiment Video

Updated: Feb 9, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
10:42

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children

Published on: December 31, 2017

17.9K

Safety of Oral Propranolol for Infantile Hemangioma

Catherine Droitcourt1,2,3,4, Sandrine Kerbrat4, Caroline Rault4

  • 1University of Rennes, Rennes, France; catherine.droitcourt@chu-rennes.fr.

Pediatrics
|May 31, 2018
PubMed

Insights

Oral propranolol is safe for treating infantile hemangioma in healthy children. This population-level study found no significant safety concerns, confirming its good safety profile.

Area of Science:

  • Pediatric pharmacology
  • Dermatology
  • Public health

Background:

  • Infantile hemangioma treatment has evolved with new therapeutic options.
  • Oral propranolol is a key treatment, but population-level safety data post-authorization were lacking.
  • Assessing real-world safety is crucial for pediatric drug use.

Purpose of the Study:

  • To evaluate the safety of oral propranolol in children under 3 years old for infantile hemangioma.
  • To compare adverse event rates in treated children versus a non-exposed cohort.
  • To analyze safety in both healthy children and those with underlying conditions.

Main Methods:

  • A nationwide, French health insurance claims database was used for an observational cohort study.
  • Included children (<3 years) received oral propranolol between 2014-2016.
  • Standardized Morbidity Ratios (SMRs) assessed cardiovascular, respiratory, and metabolic events against a control group.

Main Results:

  • In healthy children (N=1484), SMRs for cardiovascular, respiratory, and metabolic events were 2.8, 1.7, and 5.1 respectively.
  • In children with underlying diseases (N=269), cardiovascular events showed a raised SMR of 6.0.
  • Respiratory and metabolic events did not show significantly raised SMRs in the non-healthy group.

Conclusions:

  • Oral propranolol demonstrates a good safety profile in healthy children treated for infantile hemangioma.
  • While cardiovascular events were elevated in children with underlying conditions, other adverse events were not significantly increased.
  • This large-scale study supports the established safety of oral propranolol in pediatric populations.
Abstract

More Related Videos

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography06:49

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography

Published on: July 22, 2022

10.3K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.7K

Related Concept Videos

Survey Safety01:28

Survey Safety

Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
413
Oral Cavity01:11

Oral Cavity

The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.2K
Household Wiring And Electrical Safety01:13

Household Wiring And Electrical Safety

Companies that supply power to most modern households use three conductors, typically called a three-wire line. While one is neutral, the other two are both at 120 V but with opposite polarity, giving a voltage of 240 V between them. With a three-wire line, high-power appliances that require 240 V, such as electric stoves and clothes dryers, are linked between the two hot lines. 120 V appliances can be connected between the neutral and either of the hot lines. The neutral side, which is always...
1.7K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
681
Psychosexual Stages of Personality: Oral01:16

Psychosexual Stages of Personality: Oral

The oral stage is the initial phase of Sigmund Freud's theory of psychosexual development, occurring from birth to approximately 12 to 18 months. During this period, the infant's mouth serves as the primary source of pleasure, with actions such as sucking, chewing, biting, and drinking playing a crucial role in reducing tension. These activities are essential not only for nourishment but also for the infant's psychological and emotional satisfaction.
Weaning, typically occurring...
3.2K
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.1K